Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Trestolone acetate
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | Orgasteron acetate; MENT acetate; CDB-903; NSC-69948; U-15614; 7α-Methyl-19-nortestosterone 17β-acetate; 7α-Methylestr-4-en-17β-ol-3-one 17β-acetate |
Routes of administration |
Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen; Antigonadotropin |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H30O3 |
Molar mass | 330.468 g·mol−1 |
3D model (JSmol) | |
| |
|
Trestolone acetate (USAN; developmental code names CDB-903, NSC-69948, U-15614; also known as 7α-methyl-19-nortestosterone 17β-acetate (MENT acetate) and 7α-methylestr-4-en-17β-ol-3-one 17β-acetate) is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed. It is an androgen ester – specifically, the C17 acetate ester of trestolone (7α-methyl-19-nortestosterone; MENT). The medication was first described in 1963.
See also
ER |
|
||||||
---|---|---|---|---|---|---|---|
GPER |
|
||||||
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||